ACPCC Partners with Cirdan to Implement ULTRA LIS

Bronagh McStravick

21st May 2024
ACPCC Partners with Cirdan to Implement ULTRA LIS
The Australian Centre for the Prevention of Cervical Cancer (ACPCC) has selected Cirdan as its chosen partner to deploy Cirdan’s state-of-the-art Laboratory Information Management System (LIMS) ULTRA, to enhance, streamline, and future-proof their laboratory workflows and processes.
The implementation of Cirdan‘s ULTRA LIMS will support ACPCC’s mission to eliminate cervical cancer in Australia by 2035.

Background and Business Need

The Australian Centre for the Prevention of Cervical Cancer (ACPCC), a not-for-profit organisation with 60 years of expertise in cervical cancer prevention, has partnered with Cirdan to implement a state-of-the-art Laboratory Information Management System (LIMS) to optimise and future-proof its laboratory workflows. Implementation will occur throughout 2024, across the pathology division of ACPCC – VCS Pathology – in Melbourne. The implementation of Cirdan’s modern and unified LIMS will serve to improve ACPCC’s laboratory efficiency by more effectively managing the flow of samples and data, and ultimately creating a centralized storage of data required for quality control compliance.

ACPCC’s vision and commitment is to prevent cancer and infectious diseases through excellence in the provision of public health services supporting screening, population based testing and vaccination. As part of its commitment, ACPCC continues to work with Australian and international partners to achieve the World Health Organization’s goal of eliminating cervical cancer as a public health problem, primarily through screening, establishment of screening and vaccination registries and laboratory strengthening.

ACPCC was attracted to Cirdan’s LIMS offering due to its ability to collect high volumes of data in a lean and expeditious way, to help reduce the time taken for patient diagnosis. The system will provide new insights into healthcare data through its ability to modernise and standardise ACPCC’s pathology workflows and processes.

Future Benefits and Impact

The new unified single LIMS system will integrate the functionality of various existing subsystems including ACPCC’s current LIMS solution which was developed in-house, a third-party LIMS solution, a scanning solution and a billing solution as well as services that allow for the communication between internal systems, instruments, and external clients. The implementation of Cirdan’s ULTRA LIMS will future-proof VCS Pathology by creating a completely digital environment, with effective sample and data management enhancing the functionality of ACPCC’s pathology workflows.

Associate Professor Dave Hawkes, Director Molecular Microbiology at ACPCC, commented that “the introduction of the new Cirdan LIMS will allow us to continue to build our versatility whilst maintaining our high quality approach to reporting patients pathology results”.

Speaking about the new partnership, Hugh Cormican, CEO at Cirdan, added “We are delighted to work with ACPCC – a global leader in the prevention of cervical cancer – and support their tremendous work in Australia and in the wider world.”

About ACPCC

ACPCC is committed to preventing cancer and infectious diseases through excellence in the provision of population health services and through hosting the Australian HPV Reference Laboratory. Through laboratory and educational services, cervical screening and testing, vaccination registries, and the delivery of digital health solutions, ACPCC continue to lead the way in cervical cancer prevention, with an overall mission to eliminate cervical cancer in Australia by 2035.

The ACPCC also has a global commitment to the elimination of this preventable disease. The centre has worked with countries such as India, Malaysia, New Zealand, Papua New Guinea and Vanuatu to implement, support, monitor and manage population health programs, including improving vaccination, screening and treatment practices. This work continues to positively impact the lives of so many, especially in lower socio-economic countries with higher rates and limited awareness of cervical cancer.

About Cirdan

Cirdan is a leading provider of informatics and imaging solutions that enhance and speed up patient diagnosis. Headquartered in the UK, with offices in Australia and North America, Cirdan is recognised as one of the leading suppliers of laboratory information systems (LIS) worldwide and one of the fastest-growing UK clinical LIS providers.

The award-winning ULTRA solution is one of the most widely used LIS in Australasia. It is deployed in numerous prestigious and diverse healthcare organisations throughout the world and is currently helping to increase efficiency and streamline operations in multiple laboratories across six continents. Find out more at www.cirdan.com or follow us on LinkedIn, Twitter and Facebook.

For media enquiries contact:

A/Prof. Misha Coleman, Government Relations and Communications Director, Australian Centre for the Prevention of Cervical Cancer. T: +61 428 399 739 E: mcoleman@acpcc.org.au W: www.acpcc.org.au

Rebecca Fitton, Marketing Manager, Cirdan. T: +44 (0) 28 9266 0880 E: rfitton@cirdan.com W: www.cirdan.com